Cardiovascular Business - January/February 2009 - (Page 12)

Device trenDs Endeavor Sprint Coronary Stent “companies need to choose advances wisely. As the price of pumps increases, the margin shrinks.” Joseph G. Rogers, MD, medical director, Cardiac Transplant and Mechanical Circulatory Support Program, Duke University Medical Center Driver Coronary Stent System Intended Use The Medtronic Driver MX2/Over-the-Wire Coronary Stent Delivery Systems are indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo or restenotic lesions with reference vessel diameters of 3.0 mm to 4.0 mm and ≤30 mm in length using direct stenting or predilatation. Contraindications therapy is contraindicated. complete in ation of an angioplasty balloon. Warnings/Precautions this device carries the associated risk of subacute thrombosis, vascular complications and/or bleeding events. and coronary vasodilator therapy is critical to successful stent implantation and follow-up. an allergic reaction to this implant. should perform implantation of the stent. where emergency coronary artery bypass graft surgery can be readily performed. the arterial segment containing the stent. The long-term outcome following repeat dilatation of endothelialized coronary stents is unknown at present. ent materials in contact with each other may increase the potential for corrosion. Data obtained from in vitro corro- Researchers have been studying the safety and efficacy of remote monitoring of such devices. A report by economist Robert Litan, “Vital Signs Via Broadband: Remote Health Monitoring Transmits Savings, Enhances Lives,” released Oct. 24, 2008, found that remotely monitoring patients with chronic diseases, such as congestive heart failure, could cut nearly $200 billion from U.S. healthcare costs over the next 25 years. The savings would come primarily by reducing emergency room visits, hospitalizations and hospital lengths of stay. The report also said that remote monitoring could improve health outcomes and quality of life. At the 2008 Heart Rhythm Society meeting, Elizabeth Ching, RN, and colleagues from the Cleveland Clinic reported that home monitoring of devices via wireless technology is increasingly being embraced by patients. During the course of the fiveyear study, remote evaluations increased from 94 to more than 5,000 patients. “This growth is a direct result of the clinic’s incorporation of ICD follow-up through remote monitoring evaluations, allowing for better time management and overall improvements in resource allocation,” Ching says. For now, VADs are not remotely monitored, which is fine with Rogers. “Companies need to choose advances wisely,” he says. “As the price of pumps increases, the margin shrinks.” Rogers would rather see companies invest in technology that allows all components of the pumps to be implanted internally. “That would improve patient acceptance and decrease morbidity associated with the devices.” increased risk of in vivo corrosion. the lesion by direct stenting and determines the lesion to be uncrossable, this patient should be treated per predilatanew stent of the same kind should then be advanced and deployed with predilatation. and/or proximal to the stented portion and may cause additional stents or other). are unknown at present. Adverse Events those listed in the Driver Instructions for Use) are death, myocardial infarction, emergency coronary artery bypass tions, stroke/cerebrovascular accidents, vascular complications, stent failures, acute myocardial infarction, myocardial perforation, restenosis of stented segments, stent embolization, total occlusion of coronary artery, cardiac tamponade, femoral pseudoaneurysm, spasm, hypotension/ hypertension, allergic reaction to drugs/contrast medium/stent mateand pain at the insertion site, and hematoma. Instructions for Use for a more detailed list of indications, warnings, precautions and potential adverse events. CAUTION or on the order of a physician. Medtronic Vascular 3576 Unocal Place Santa Rosa, CA 95403 USA Tel: 707.525.0111 www.Medtronic.com www.EndeavorStent.com CardioVascular LifeLine Customer Support Tel: 877.526.7890 Tel: 763.526.7890 Product Services Tel: 888.283.7868 Fax: 800.838.3103 12 cardiovascular Business January/February 2009 http://www.Medtronic.com http://www.EndeavorStent.com

Table of Contents Feed for the Digital Edition of Cardiovascular Business - January/February 2009

Cardiovascular Business - January/February 2009 Contents First Word Electrophysiology Roundtable Forum: A Candid Conversation about Profits, Procedures and Patients Heart Failure Care Gets Boost from Technology Emerging Technologies in Peripheral Vascular Interventions Stent vs. Graft: Choosing the Best Path for the Diabetic Patient with Multivessel Disease Cardiology Groups and Hospitals Strive to ‘Connect’ Seamlessly CT Beyond 64 Slices Clinical Study Digest: Kidney Disease & PCI; Women and Valve Disease Compact Echo Systems Come Up Big in Cardiac Care News & Views Reader Resources The ACC Corner

Cardiovascular Business - January/February 2009

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.